- Conditions
- Ocular Rosacea, Antimicrobial Resistance
- Interventions
- Doxycycline 40 MG ( 20mg twice daily), Doxycycline 200 MG ( 100 mg twice daily), Placebo
- Drug
- Lead sponsor
- University of California, San Francisco
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 46 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2025
- U.S. locations
- 1
- States / cities
- San Francisco, California
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–4
of 4
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Urethritis
- Interventions
- Doxycycline, Placebo, Tinidazole, Azithromycin
- Drug · Other
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Eligibility
- 16 Years to 45 Years · Male only
- Enrollment
- 305 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2009
- U.S. locations
- 4
- States / cities
- Birmingham, Alabama • New Orleans, Louisiana • Baltimore, Maryland + 1 more
- Conditions
- Covid19
- Interventions
- Ivermectin Tablets, Doxycycline Tablets, Placebo
- Drug
- Lead sponsor
- Max Health, Subsero Health
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 150 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2022
- U.S. locations
- 1
- States / cities
- Sarasota, Florida
- Conditions
- Urogential Chlamydia Trachomatis Infection
- Interventions
- Doxycyline Hyclate tablet, Vibramycin (doxycyline hyclate) capsule
- Drug
- Lead sponsor
- Warner Chilcott
- Industry
- Eligibility
- 19 Years to 45 Years
- Enrollment
- 495 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010
- U.S. locations
- 43
- States / cities
- Birmingham, Alabama • Foley, Alabama • Tucson, Arizona + 38 more